Manufacturer Astellas has stopped producing the antibiotic vilprafen worldwide
Pharmaceutical manufacturer Astellas has decided to stop producing the antibiotic vilprafen not only in Russia, but also on the world...
Pharmaceutical manufacturer Astellas has decided to stop producing the antibiotic vilprafen not only in Russia, but also on the world...
The French pharmaceutical manufacturer Sanofi cannot fully fulfill its obligations under the special investment contract (SPIC). Due to logistical problems,...
German pharmaceutical manufacturer Bayer refused to receive compensation from the Spectr company, which until June 2022 was called Nativa, in...
German pharmaceutical manufacturer Bayer refused compensation of more than 400 million rubles. from Nativa (renamed Spectrum) for the use of...
Swiss pharmaceutical manufacturer Roche Holding has entered into an agreement with Roivant Sciences and Pfizer to purchase their joint venture...
Despite statements by international pharmaceutical companies about the suspension of new trials in Russia after the outbreak of hostilities in...
A medical research company (MRC), which tried to force the American Vertex to license the expensive cystic fibrosis drug Trikafta,...
American Pfizer is trying to recover more than 12.5 billion rubles from the bankrupt Nativa. Most likely, the pharmaceutical manufacturer...
The American pharmaceutical manufacturer MSD will stop deliveries to Russia of Zepatier, one of the most popular drugs against hepatitis...
The appearance on the Russian market at once of three generics based on raltegravir, prescribed to patients with HIV, forced...
Japanese pharmaceutical manufacturer Takeda is considering selling its Russian plant, which has invested more than €117 million. The site produces...
Eli Lilly became the second American pharmaceutical manufacturer after Bristol-Myers Squibb (BMS) to leave Russia for good. The company can...